Jeff Y. Yang

862 total citations · 1 hit paper
20 papers, 506 citations indexed

About

Jeff Y. Yang is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Jeff Y. Yang has authored 20 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Surgery and 6 papers in Oncology. Recurrent topics in Jeff Y. Yang's work include Colorectal Cancer Screening and Detection (4 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (4 papers). Jeff Y. Yang is often cited by papers focused on Colorectal Cancer Screening and Detection (4 papers), Inflammatory Bowel Disease (4 papers) and Microscopic Colitis (4 papers). Jeff Y. Yang collaborates with scholars based in United States, China and India. Jeff Y. Yang's co-authors include Virginia Pate, Anne F. Peery, Til Stürmer‎, Jennifer L. Lund, Robert S. Sandler, Andrew M. Moon, A. Sidney Barritt, Michael D. Kappelman, Ramón Bataller and James D. Lewis and has published in prestigious journals such as Gastroenterology, Diabetes Care and Cancer.

In The Last Decade

Jeff Y. Yang

19 papers receiving 499 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States

2023 152 citations James D. Lewis, Lauren E. Parlett et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Y. Yang United States	12	169	150	120	102	73	20	506
Hafeez Shaka United States	11	101 0.6×	101 0.7×	60 0.5×	48 0.5×	96 1.3×	100	489
Raffi Karagozian United States	14	332 2.0×	198 1.3×	52 0.4×	49 0.5×	80 1.1×	52	658
Virginia Nguyen United States	10	331 2.0×	171 1.1×	42 0.3×	93 0.9×	47 0.6×	14	774
Brian Radbill United States	10	98 0.6×	81 0.5×	44 0.4×	52 0.5×	30 0.4×	12	426
Ravinder Garg India	13	155 0.9×	104 0.7×	31 0.3×	102 1.0×	20 0.3×	48	522
Hiba Masri‐Iraqi Israel	10	87 0.5×	151 1.0×	37 0.3×	227 2.2×	66 0.9×	31	526
Farrukh M. Koraishy United States	13	297 1.8×	97 0.6×	161 1.3×	34 0.3×	35 0.5×	34	864
Prabha Sawant India	15	267 1.6×	303 2.0×	62 0.5×	45 0.4×	72 1.0×	70	651
P.F. Westeel France	12	125 0.7×	132 0.9×	19 0.2×	67 0.7×	73 1.0×	25	689
Michael Huang Canada	19	286 1.7×	295 2.0×	244 2.0×	52 0.5×	30 0.4×	52	885

Countries citing papers authored by Jeff Y. Yang

Since Specialization

Citations

This map shows the geographic impact of Jeff Y. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Y. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Y. Yang more than expected).

Fields of papers citing papers by Jeff Y. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Y. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Y. Yang. The network helps show where Jeff Y. Yang may publish in the future.

Co-authorship network of co-authors of Jeff Y. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Y. Yang. A scholar is included among the top collaborators of Jeff Y. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Y. Yang. Jeff Y. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jeff Y., Jennifer L. Lund, Michele Jönsson Funk, et al.. (2023). Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 118(9). 1638–1647. 7 indexed citations

Lewis, James D., Lauren E. Parlett, Colleen Brensinger, et al.. (2023). Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States. Gastroenterology. 165(5). 1197–1205.e2. 152 indexed citations breakdown →

Dawwas, Ghadeer K., Alexandra Weiss, Brad D. Constant, et al.. (2023). Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases. Inflammatory Bowel Diseases. 29(12). 1993–1996. 11 indexed citations

Zalla, Lauren C., Jeff Y. Yang, Jessie K. Edwards, & Stephen R. Cole. (2022). Leveraging auxiliary data to improve precision in inverse probability-weighted analyses. Annals of Epidemiology. 74. 75–83. 3 indexed citations

Yang, Jeff Y., Jennifer L. Lund, Virginia Pate, & Michael D. Kappelman. (2022). Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019. Inflammatory Bowel Diseases. 29(5). 735–743. 5 indexed citations

Li, Xiaotong, Alan C. Kinlaw, Edward L. Barnes, et al.. (2022). Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data. UNC Libraries. 1 indexed citations

Garg, Nidhi, Jeff Y. Yang, Renée Pekmezaris, et al.. (2021). Acuity patterns of heart failure among emergency departments in a large health system. The American Journal of Emergency Medicine. 43. 21–26.

Tang, Huilin, Liyuan Zhou, Xiaotong Li, et al.. (2021). Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data. International Journal of Clinical Pharmacy. 43(4). 1116–1122. 12 indexed citations

Yang, Jeff Y., Tiansheng Wang, Virginia Pate, John B. Buse, & Til Stürmer‎. (2020). Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene. BMJ Open Diabetes Research & Care. 8(1). e000985–e000985. 23 indexed citations

10.

Wheeler, Stephanie B., Meghan C. O’Leary, Jeff Y. Yang, et al.. (2020). Comparative cost‐effectiveness of mailed fecal immunochemical testing (FIT)–based interventions for increasing colorectal cancer screening in the Medicaid population. Cancer. 126(18). 4197–4208. 15 indexed citations

11.

Yang, Jeff Y., Andrew M. Moon, Hannah Kim, et al.. (2020). Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. Journal of Diabetes and its Complications. 34(11). 107706–107706. 7 indexed citations

12.

Li, Dandan, Jocelyn A. Silvester, Matthew J. Crowley, et al.. (2020). Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting. Therapeutic Advances in Chronic Disease. 11. 1754196077–1754196077. 1 indexed citations

13.

Yang, Jeff Y., Michael Webster‐Clark, Jennifer L. Lund, et al.. (2019). Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research. Gastrointestinal Endoscopy. 90(3). 360–369. 38 indexed citations

14.

Yang, Jeff Y., Tiansheng Wang, Virginia Pate, et al.. (2019). Sodium‐glucose co‐transporter‐2 inhibitor use and risk of lower‐extremity amputation: Evolving questions, evolving answers. Diabetes Obesity and Metabolism. 21(5). 1223–1236. 28 indexed citations

15.

Wang, Tiansheng, Jeff Y. Yang, John B. Buse, et al.. (2019). Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults. Diabetes Care. 42(11). 2065–2074. 10 indexed citations

16.

Moon, Andrew M., Jeff Y. Yang, A. Sidney Barritt, Ramón Bataller, & Anne F. Peery. (2019). Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century. The American Journal of Gastroenterology. 115(1). 79–87. 63 indexed citations

17.

Yang, Jeff Y., Anne F. Peery, Jennifer L. Lund, Virginia Pate, & Robert S. Sandler. (2019). Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014. The American Journal of Gastroenterology. 114(5). 798–803. 36 indexed citations

18.

Yang, Jeff Y., et al.. (2018). Risks of diabetic foot syndrome and amputation associated with sodium glucose co-transporter 2 inhibitors: A Meta-analysis of Randomized Controlled Trials. Diabetes & Metabolism. 44(5). 410–414. 47 indexed citations

19.

Brenner, Alison T., Jeff Y. Yang, Dana Lee Baker, et al.. (2018). Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for M edicaid beneficiaries at a large county health department: A randomized controlled trial. Cancer. 124(16). 3346–3354. 36 indexed citations

20.

Willy, Mary E., David J. Graham, Judith A. Racoosin, et al.. (2014). Candidate Metrics for Evaluating the Impact of Prescriber Education on the Safe Use of Extended-Release/Long-Acting (ER/LA) Opioid Analgesics. Pain Medicine. 15(9). 1558–1568. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact